Prelude Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRLD and other ETFs, options, and stocks.

About PRLD

Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. 

CEO
Krishna Vaddi
CEOKrishna Vaddi
Employees
131
Employees131
Headquarters
Wilmington, Delaware
HeadquartersWilmington, Delaware
Founded
2016
Founded2016
Employees
131
Employees131

PRLD Key Statistics

Market cap
46.07M
Market cap46.07M
Price-Earnings ratio
-0.44
Price-Earnings ratio-0.44
Dividend yield
Dividend yield
Average volume
287.85K
Average volume287.85K
High today
$0.82
High today$0.82
Low today
$0.78
Low today$0.78
Open price
$0.80
Open price$0.80
Volume
60.44K
Volume60.44K
52 Week high
$6.80
52 Week high$6.80
52 Week low
$0.6101
52 Week low$0.6101

People also own

Based on the portfolios of people who own PRLD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.